Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenomics and Pharmacometabolomics of Acamprosate Treatment Outcome

NCT03818191 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03818191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03818191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenomics and Pharmacometabolomics of Acamprosate Treatment Outcome
Lead sponsor
Mayo Clinic
Phase
Phase 4
Overall status
Completed
Start date
July 15, 2019
Completion date
November 4, 2023
Enrollment
288 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder